Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.
Introduction
AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (hGH). Originally characterized for its lipolytic, or fat-metabolizing, activity, the fragment has since drawn interest in a very different research area: the biology of cartilage and the chondrocytes that build and maintain it. Because AOD-9604 reproduces only a short segment of the parent hormone, investigators have used it as a tool to ask whether this isolated region carries any signaling activity relevant to joint tissue, separate from the full growth hormone molecule.
This overview surveys how AOD-9604 is studied in cartilage, chondrocyte, and osteoarthritis model systems. The focus is strictly preclinical: cell culture, tissue explants, and animal models used to generate laboratory data. Nothing here describes human treatment, dosing, or clinical outcomes. Researchers evaluating the compound for laboratory work can review the AOD-9604 research listing and the broader research peptide catalog for reference documentation.
What Is AOD-9604?
Molecular Identity
AOD-9604 corresponds to the growth hormone sequence spanning roughly residues 176 to 191, presented as a Tyr-hGH(177-191) analog with an N-terminal tyrosine added to support synthesis and handling. Where native hGH is a 191-amino-acid protein, AOD-9604 is a compact fragment of about 16 residues with a reported mass near 1.8 kDa. This small size is central to the research rationale: it lets investigators probe a specific region of the hormone without the receptor and metabolic complexity of the complete molecule.
The values below reflect commonly reported laboratory attributes and are provided for comparison only.
| Attribute | Commonly Reported Value |
|---|---|
| Compound | AOD-9604 |
| Class | Synthetic hGH C-terminal fragment |
| Parent region | Human growth hormone residues 176-191 |
| Sequence note | Tyr-hGH(177-191) analog |
| Approx. sequence length | 16 amino acids |
| Approx. molecular weight | 1815 Da (about 1.8 kDa) |
| Reported molecular formula | C78H123N23O23S2 |
| Research focus (this article) | Cartilage, chondrocyte, osteoarthritis models |
Cartilage, Chondrocytes, and the Research Rationale
Articular cartilage is a dense, avascular connective tissue that cushions the ends of bones within a joint. Its only resident cell type is the chondrocyte, which synthesizes and remodels the surrounding extracellular matrix (ECM), a network dominated by type II collagen and large proteoglycans such as aggrecan. Because cartilage has no direct blood supply, its intrinsic capacity for self-repair is limited, which is precisely why the degenerative changes modeled under the label of osteoarthritis remain a persistent focus of tissue research.
Why AOD-9604 Attracted Attention
Growth hormone signaling has long been associated with skeletal and connective tissue development, so researchers questioned whether the C-terminal fragment retained any influence on chondrocyte behavior. Preclinical programs therefore examined AOD-9604 in matrix-focused assays, tracking readouts such as chondrocyte proliferation, collagen and proteoglycan expression, and markers linked to cartilage matrix turnover. The interest is mechanistic: understanding what the fragment does at the cell level in a controlled model, not asserting any outcome in living subjects.
AOD-9604 in Preclinical Cartilage and Osteoarthritis Models
In-Vitro Chondrocyte and Explant Studies
At the cell-culture level, AOD-9604 has been applied to isolated chondrocytes and cartilage explants to observe how the fragment associates with matrix-synthesis pathways. Endpoints in this kind of work typically include type II collagen and aggrecan gene or protein expression, cell viability, and indicators of matrix-degrading enzyme activity. These assays are designed to characterize behavior in a dish, and their outputs are interpreted as model data rather than as predictions of any physiological response.
Animal Osteoarthritis Models
Beyond cell culture, joint-degeneration models in rodents and rabbits provide a whole-tissue context. Investigators induce cartilage damage through chemical means (for example, collagenase or monosodium iodoacetate) or through surgical destabilization of a joint, then apply histology and scoring systems to compare cartilage structure across experimental groups. Such models are standard tools for studying cartilage-associated compounds and are widely referenced in the broader recovery and tissue-repair research literature.
Combination and Delivery Approaches
Some preclinical formulations have paired AOD-9604 with hyaluronic acid, a natural component of joint fluid, to study how a carrier matrix influences peptide behavior within a model joint environment. Combination designs let researchers separate the contribution of the peptide from that of the delivery vehicle. Across every one of these formats, the compound remains a laboratory material: for research use only, not for human consumption.
The categories below reflect commonly reported laboratory approaches and are provided for comparison only.
| Model Type | Typical System | Common Readouts |
|---|---|---|
| In-vitro chondrocyte | Isolated or cultured chondrocytes | Type II collagen, aggrecan, viability |
| Cartilage explant | Ex-vivo tissue pieces | Matrix synthesis and turnover |
| Chemically induced OA | Collagenase or MIA in rodents | Histology, cartilage scoring |
| Surgically induced OA | Joint destabilization in rodents or rabbits | Structural grading over time |
AOD-9604 Alongside Other Recovery-Associated Research Peptides
AOD-9604 is frequently discussed next to other peptides that appear in tissue-repair research, although each is structurally distinct and studied on its own terms. The comparison below is orientation only; it does not imply equivalence of activity or any shared outcome. The values reflect commonly reported laboratory attributes and are provided for comparison only.
| Peptide | Class | Approx. Molecular Weight | Common Preclinical Research Focus |
|---|---|---|---|
| AOD-9604 | hGH C-terminal fragment | ~1.8 kDa | Fat metabolism; cartilage and chondrocyte models |
| BPC-157 | Synthetic pentadecapeptide | ~1.4 kDa | Soft-tissue and gut repair models |
| TB-500 | Thymosin beta-4 fragment | ~0.9 kDa | Cell migration and remodeling models |
| GHK-Cu | Copper tripeptide complex | ~0.34 kDa | Matrix remodeling and skin models |
For context, BPC-157 and TB-500 are studied largely in soft-tissue and remodeling systems, while GHK-Cu is examined in matrix and skin research. AOD-9604 occupies a distinct niche as a growth hormone fragment evaluated in cartilage-focused models, which is what keeps it a recurring subject in chondrocyte and osteoarthritis literature.
Handling and Research Documentation Notes
AOD-9604 is commonly supplied as a lyophilized powder, and the 5 mg vial is a typical laboratory format. As a worked example only, reconstituting a 5 mg vial with 2 mL of bacteriostatic water yields a concentration of 2.5 mg/mL; the bacteriostatic water guide covers general reconstitution practice in detail. Like most peptides, it is generally kept cold and protected from repeated freeze-thaw cycles to preserve integrity for analytical work.
Because model data are only as reliable as the material behind them, verifying identity and purity matters before any cartilage or chondrocyte study begins. Reviewing a certificate of analysis, as outlined in the COA and purity guide, helps ensure that an experiment starts from a well-characterized peptide rather than an unverified powder.
Frequently Asked Questions
What is AOD-9604 studied for in cartilage research?
In preclinical and in-vitro research, AOD-9604 is studied as a fragment of human growth hormone that may associate with chondrocytes, the cells responsible for building and maintaining cartilage. Laboratory work has examined its relationship to cartilage matrix components such as type II collagen and proteoglycans within model systems, not in human subjects.
How is AOD-9604 related to human growth hormone?
AOD-9604 corresponds to the C-terminal region of human growth hormone (approximately residues 176 to 191) with an added tyrosine. It represents only a small fragment of the full 191-amino-acid hormone and was originally characterized for its lipolytic, or fat-metabolizing, properties in research settings.
What preclinical models are used to study AOD-9604 and osteoarthritis?
Researchers have used cultured chondrocytes, cartilage explants, and animal models of joint degeneration (such as chemically induced or surgically induced osteoarthritis in rodents and rabbits) to explore how AOD-9604 behaves in cartilage-related systems. These are laboratory models used to generate data, not clinical treatments.
Is AOD-9604 the same as BPC-157 or TB-500?
No. AOD-9604 is a growth hormone fragment, while BPC-157 is a synthetic pentadecapeptide and TB-500 is a thymosin beta-4 fragment. They are structurally distinct and are studied in different preclinical contexts, even though all three appear in tissue-repair research discussions.
What is the molecular weight of AOD-9604?
AOD-9604 has a commonly reported molecular weight of approximately 1815 Da (about 1.8 kDa) and a sequence length of roughly 16 amino acids. These figures reflect commonly reported laboratory attributes and are provided for reference only.
Is AOD-9604 approved for human or clinical use?
No. AOD-9604 is a research compound intended for research use only, not for human consumption. The literature discussed here reflects preclinical and laboratory investigation, and no human therapeutic or efficacy claims are made.
References and Further Reading
- Metabolic Pharmaceuticals and colleagues, foundational characterization of the growth hormone fragment AOD-9604. PubMed: AOD-9604
- Research on AOD-9604 in osteoarthritis and cartilage model systems. PubMed: AOD9604 osteoarthritis
- Studies of the human growth hormone C-terminal fragment (residues 176-191). PubMed: growth hormone fragment 176-191
- Chondrocyte biology and cartilage extracellular matrix synthesis. PubMed: chondrocyte cartilage matrix
- Type II collagen and aggrecan expression in cartilage research. PubMed: type II collagen aggrecan
- Animal models of osteoarthritis and cartilage degeneration. PubMed: osteoarthritis animal model cartilage
- Hyaluronic acid as a delivery matrix in joint and cartilage research. PubMed: hyaluronic acid cartilage
